Subscribe
type here...
Subscribe

Drug Development

Genetico Invests 50 Million Rubles in Development of Drugs for Heart Diseases

Drug Development Pharma -
Genetico Center (part of the Artgen Biotech group) invests in the biotechnology startup Cardiogenex, which specializes in creating gene therapy drugs for the treatment...

FEFU to Launch Russia’s First University-Based GMP Site for Biologics

Drug Development Pharma -
Far Eastern Federal University (FEFU) has announced plans to establish a comprehensive infrastructure for the development and commercialization of biotech products.
spot_imgspot_img

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Drug Development Pharma -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Global Markets Pharma -
Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

GSK comes close to creating a hard-to-reach RSV vaccine

Drug Development Pharma -
GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim...

Code Biotherapeutics raises $75 Million to advance programs to treat and cure rare and prevalent genetic diseases

Drug Development Pharma -
Code Biotherapeutics, Inc., (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized...

Emmes launches Advantage eClinical as a stand-alone cloud-based clinical platform

Drug Development Pharma -
The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is...

Open Orphan signs a £7.3 million contract for influenza human challenge study

Drug Development Pharma -
Open Orphan PLC said Wednesday that its hVIVO subsidiary has signed a 7.3 million pounds ($9.1 million) influenza human...
Load more

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Change of Leader: Rating of Pharmaceutical Companies in the Russian Market for 2025

0
The Russian retail pharmaceutical market, which reached a volume...

Roche Challenges Leaders: New Drug Shows 22.5% Weight Loss in 48 Weeks

0
Swiss pharmaceutical giant Roche published positive Phase II results...

Battle of Brands 2025: Rise of Russian Blockbusters and Fall of Old Giants

0
The Russian retail pharmaceutical market, which reached a volume...

Genetico Invests 50 Million Rubles in Development of Drugs for Heart Diseases

0
Genetico Center (part of the Artgen Biotech group) invests...

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026